HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/2/L405    most recent 00232.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Huang, S. Articles by Peters-Golden, M. Search for Related Content PubMed PubMed Citation Articles by Huang, S. Articles by Peters-Golden, M.

Prostaglandin E₂ inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling

Divisions of ¹Pulmonary and Critical Care Medicine and ²Infectious Disease, Department of Internal Medicine, and ³Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan

Submitted 21 June 2006 ; accepted in final form 1 October 2006

Uncontrolled fibroblast activation is one of the hallmarks of fibrotic lung disease. Prostaglandin E₂ (PGE₂) has been shown to inhibit fibroblast migration, proliferation, collagen deposition, and myofibroblast differentiation in the lung. Understanding the mechanisms for these effects may provide insight into the pathogenesis of fibrotic lung disease. Previous work has focused on commercially available fibroblast cell lines derived from tissue whose precise origin and histopathology are often unknown. Here, we sought to define the mechanism of PGE₂ inhibition in patient-derived fibroblasts from peripheral lung verified to be histologically normal. Fibroblasts were grown from explants of resected lung, and proliferation and collagen I expression was determined following treatment with PGE₂ or modulators of its receptors and downstream signaling components. PGE₂ inhibited fibroblast proliferation by 33% and collagen I expression by 62%. PGE₂ resulted in a 15-fold increase in intracellular cAMP; other cAMP-elevating agents inhibited collagen I in a manner similar to PGE₂. These effects were reproduced by butaprost, a PGE₂ analog selective for the cAMP-coupled E prostanoid (EP) 2 receptor, but not by selective EP3 or EP4 agonists. Fibroblasts expressed both major cAMP effectors, protein kinase A (PKA) and exchange protein activated by cAMP-1 (Epac-1), but only a selective PKA agonist was able to appreciably inhibit collagen I expression. Treatment with okadaic acid, a phosphatase inhibitor, potentiated the effects of PGE₂. Our data indicate that PGE₂ inhibits fibroblast activation in primary lung fibroblasts via binding of EP2 receptor and production of cAMP; inhibition of collagen I proceeds via activation of PKA.

E prostanoid receptor; protein kinase A; exchange protein activated by cAMP-1; okadaic acid; pulmonary fibrosis

This article has been cited by other articles:

				S. Haag, S. Matthiesen, U. R. Juergens, and K. Racke Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts Eur. Respir. J., September 1, 2008; 32(3): 555 - 562. [Abstract] [Full Text] [PDF]

				P. E. Thomas, M. Peters-Golden, E. S. White, V. J. Thannickal, and B. B. Moore PGE2 inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L417 - L428. [Abstract] [Full Text] [PDF]